Coital pain in the elderly: could a low dose estriol gel thrill the vulvar vestibule?

[1]  M. Falagas,et al.  Microablative fractional CO2 laser for the genitourinary syndrome of menopause: power of 30 or 40 W? , 2017, Lasers in Medical Science.

[2]  A. Lethaby,et al.  Local oestrogen for vaginal atrophy in postmenopausal women. , 2016, The Cochrane database of systematic reviews.

[3]  D. Portman,et al.  Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. , 2014, Maturitas.

[4]  D. Portman,et al.  Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society , 2014, Climacteric : the journal of the International Menopause Society.

[5]  M. J. Minkin,et al.  Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therapy , 2014, International journal of women's health.

[6]  Hong Li,et al.  Histopathologic Characteristics of Menopausal Vestibulodynia , 2013, Obstetrics and gynecology.

[7]  M. Martens,et al.  Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society , 2013, Menopause.

[8]  A. Cano,et al.  The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study , 2012, Menopause.

[9]  R. Amsel,et al.  Biopsychosocial predictors of postmenopausal dyspareunia: the role of steroid hormones, vulvovaginal atrophy, cognitive-emotional factors, and dyadic adjustment. , 2012, The journal of sexual medicine.

[10]  T. Griebling,et al.  Systemic and topical hormone therapies reduce vaginal innervation density in postmenopausal women , 2012, Menopause.

[11]  R. Amsel,et al.  Challenging Atrophied Perspectives on Postmenopausal Dyspareunia: A Systematic Description and Synthesis of Clinical Pain Characteristics , 2012, Journal of sex & marital therapy.

[12]  David S. Jones,et al.  Vaginal gel drug delivery systems: understanding rheological characteristics and performance , 2011, Expert opinion on drug delivery.

[13]  J. Manson,et al.  Correlates of Sexual Satisfaction Among Sexually Active Postmenopausal Women in the Women’s Health Initiative-Observational Study , 2008, Journal of General Internal Medicine.

[14]  L. Dennerstein,et al.  The frequency of sexual intercourse reported by women: a review of community-based studies and factors limiting their conclusions. , 2008, The journal of sexual medicine.

[15]  R. Straub,et al.  The complex role of estrogens in inflammation. , 2007, Endocrine reviews.

[16]  I. Goldstein,et al.  Women's Sexual Function and Dysfunction: Study, Diagnosis and Treatment , 2005 .

[17]  M. Moyal-Barracco,et al.  2003 ISSVD terminology and classification of vulvodynia: a historical perspective. , 2004, The Journal of reproductive medicine.

[18]  A. Ting,et al.  Estrogen Regulates Vaginal Sensory and Autonomic Nerve Density in the Rat1 , 2004, Biology of reproduction.

[19]  E. Zoubina,et al.  Sympathetic hyperinnervation of the uterus in the estrogen receptor α knock-out mouse , 2001, Neuroscience.

[20]  M. Goetsch.  Postpartum dyspareunia : An unexplored problem , 1999 .

[21]  M. Turner,et al.  Vulvar vestibulitis syndrome: an overview. , 1991, American journal of obstetrics and gynecology.